Keyword Search
Sessions Were Renumbered as of May 19.
Legend:
CC-W = McCormick Place Convention Center, West Building, CC-N = McCormick Place Convention Center, North Building
H = Hilton Chicago, UC= Conference Chicago at University Center
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: type I error returned 17 record(s)
|
|
Monday, 08/01/2016
|
The Impact of Regional Baseline Variation on the Type I Error and Power of Multiregional Clinical Trials
Weining Robieson, AbbVie; Jun Zhao, AbbVie
|
Noninferiority Studies with Multiple Reference Treatments and Heterogeneous Variances
Li-Ching Huang; Miin-Jye Wen, National Cheng Kung University; Yu Shyr, Vanderbilt University
|
Confounder Adjustments by Propensity Score and Disease Risk Score in the Early Stage of Post-Marketing Drug Safety Surveillance
Tae Hyun Jung, Yale University; Jessica Kim , FDA
|
Comparing Performance of Tests for One-Factor ANOVA Models Under Heterogeneity and Non-Normality: A Monte Carlo Simulation Study
Thanh Pham, University of South Florida; Yan Wang, University of South Florida; Diep Nguyen, University of South Florida; Eun Sook Kim, University of South Florida; Jeffrey Kromrey, University of South Florida; Yi-Hsin Chen, University of South Florida
|
Is Type I error control for multiplicity really "out of the picture" in epidemiology?
Yueqin Zhao, FDA/CDER; Rima Izem, FDA; Mark Levenson, FDA
|
|
Tuesday, 08/02/2016
|
Covariate Adjustment for Logistic Regression Analysis of Binary Clinical Trial Data
Honghua Jiang; Pandurang Kulkarni, Eli Lilly and Company; Craig Mallinckrodt, Eli Lilly and Company; Linda Shurzinske, Eli Lilly and Company; Geert Molenberghs, Universiteit Hasselt; Ilya Lipkovich, Quintiles
|
The Covering Principle: A New Approach to Address Multiplicity in Hypothesis Testing
Huajiang Li, Allergan; Jihao Zhou, Allergan
8:35 AM
|
Covariate Adjustment for Logistic Regression Analysis of Binary Clinical Trial Data
Honghua Jiang; Pandurang Kulkarni, Eli Lilly and Company; Craig Mallinckrodt, Eli Lilly and Company; Linda Shurzinske, Eli Lilly and Company; Geert Molenberghs, Universiteit Hasselt; Ilya Lipkovich, Quintiles
9:10 AM
|
|
Wednesday, 08/03/2016
|
Statistical Inference of Covariate-Adjusted Response-Adaptive Randomized Clinical Trials
Wanying Zhao, The George Washington University
|
Statistical Inference of Covariate-Adjusted Response-Adaptive Randomized Clinical Trials
Wanying Zhao, The George Washington University
8:35 AM
|
Sample Size Re-Estimation in a Two-Stage Cross-Over Trial for Testing for Average Bioequivalence
Byron Jones, Novartis Pharma; Will Maurer, Novartis Pharma AG; Ying Chen, Shanghai University of Finance and Economics
9:20 AM
|
Design of Primary and Sensitivity Analyses for Handling Nonfuture Dependence Missing Data in Clinical Trials with an Emphasis on the Type I Error Rate Using Pattern Mixture Model
Lixian Peng, Celgene; Weichung J. Shih, Rutgers University
2:35 PM
|
A Simulation Study to Compare Multiple Imputation Methods Under Missing Not-at-Random Assumption
David Li, Pfizer; Lingfeng Yang, BMS
3:20 PM
|
|
Thursday, 08/04/2016
|
Use of the VG (Virtual Twins Combined with GUIDE) Method in the Development of Precision Medicines
Jia Jia; Qi Tang, AbbVie; Wangang Xie, AbbVie; Richard A. Rode, AbbVie
8:35 AM
|
How to Decide When to Borrow Historical Data for a Clinical Trial
Qi Tang, AbbVie; Martin King, AbbVie; Ran Liu, AbbVie; Bo Fu, AbbVie; Sandra Lovell, AbbVie; Alan Hartford, AbbVie
11:55 AM
|
|
|
